Yes, if your doctor determines it remains medically appropriate and beneficial
Understanding your genetic predispositions helps your provider optimize your specific medication and dosing protocol from month two onward
Key Clinical Evidence Phase 2 Randomized Trial in Obesity (48 weeks) Jastreboff AM et al., New England Journal of Medicine, 2023 ClinicalTrials.gov: NCT04881760 The Phase 2 study evaluated multiple doses of retatrutide versus placebo over 48 weeks

In addition, nine studies of these studies were performed in Egypt (Reference Badawy, State and Abdelgawad13,Reference Hassan, Alalfy and Hassan18,Reference Badawy, El Nashar and El Totongy20,Reference Elnashar, Fahmy and Mansour21,Reference Hashim, Anwar and El-Fatah22,Reference Nasr9,Reference Elgindy, El-Huseiny and Mostafa23,Reference Maged, Elsawah and Abdelhafez8,Reference El Sharkwy and Abd El Aziz24) , four in Iran (Reference Nemati, Nemati and Taheri12,Reference Ghomian, Khadem and Moeindarbari5,Reference Teimouri, Mollashahi and Paracheh7,Reference Cheraghi, Mehranjani and Shariatzadeh25) , two in Turkey (Reference Kose and Naziroglu26,Reference Oner and Muderris11) , two in India (Reference Chandil, Pande and Sen27,Reference Gayatri, Kumar and Kumar28) and one in Italy (Reference Fulghesu, Ciampelli and Muzj29)
She had a full abdominoplasty procedure with 1.6kg of tissue removed, together with tightening (plication) of her abdominal muscles (no mesh required)
Source: Moeller, M